01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

Duke RC, Ojcius DM, and Young JD-E (1996) Cell suicide in
health and disease. Scientifc Amer 275, 80-87.
Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M,
Auerbach A, Breitman ML (1994) Dominant-negative and
targeted null mutations in the endothelial receptor tyrosine
kinase, tek, reveal a critical role in vasculogenesis of the
embryo. Genes Dev 8, 1897-1909.
Dunbar C and Kohn D (1996) Retroviral mediated transfer of the
cDNA for human glucocerebrosidase into hematopoietic
stem cells of patients with Gaucher disease. A phase I study.
Hum Gene Ther 7, 231-253.
Dunlap DD, Maggi A, Soria MR, Monaco L (1997) Nanoscopic
structure of DNA condensed for gene delivery. Nucleic
Acids Res 25, 3095-3101.
Dupuit F, Chinet T, Zahm JM, Pierrot D, Hinnrasky J, Kaplan H,
Bonnet N, Puchelle E (1997) Induction of a cAMPstimulated
chloride secretion in regenerating poorly
differentiated airway epithelial cells by adenovirus-mediated
CFTR gene transfer. Hum Gene Ther 8, 1439-1450.
During MJ, Naegele JR, O'Malley KL, Geller AI (1994) Longterm
behavioral recovery in Parkinsonian rats by an HSV
Vector expressing tyrosine hydroxylase. Science 266, 1399-
1403.
Dutta A, Ruppert JM, Aster JC and Winchester E (1993)
Inhibition of DNA replication factor RPA by p53. Nature
365: 79-82.
Dwarki VJ, Belloni P, Nijjar T, Smith J, Couto L, Rabier M,
Clift S, Berns A, and Cohen LK (1995) Gene therapy for
hemophilia A: Production of therapeutic levels of human
factor VIII in vivo in mice. Proc Natl Acad Sci USA 92,
1023-1027.
Dyson, N., Howley, P.M., Münger, K. and Harlow, E. (1989)
The human papilloma virus-16 E7 oncoprotein is able to bind
to the retinoblastoma gene product. Science 243, 934-937.
Ealovega MW, McGinnis PK, Sumantran VN, Clarke MF,
Wicha MS (1996) bcl-xs gene therapy induces apoptosis of
human mammary tumors in nude mice. Cancer Res 56,
1965-1969.
Eastham JA, Chen S-H, Sehgal I, Yang G, Timme TL, Hall SJ,
Woo SLC, and Thompson TC (1996) Prostate cancer gene
therapy: herpes simplex virus thymidine kinase gene
transduction followed by ganciclovir in mouse and human
prostate cancer models. Hum Gene Ther 7, 515-523.
Eastham JA, Hall SJ, Sehgal I, Wang J, Timme TL, Yang G,
Connell-Crowley L, Elledge SJ, Zhang W-W, Harper JW,
and Thompson TC (1995) In vivo gene therapy with p53 or
p21 adenovirus for prostate cancer. Cancer Res 55, 5151-
5155.
Ebbinghaus SW, Vigneswaran N, Miller CR, Chee-Awai RA,
Mayfield CA, Curiel DT, Miller DM (1996) Efficient
delivery of triplex forming oligonucleotides to tumor cells by
adenovirus-polylysine complexes. Gene Ther 3, 287-297.
Eckert HG, Stockschlader M, Just U, Hegewisch-Becker S, Grez
M, Uhde A, Zander A, Ostertag W, Baum C (1996) Highdose
multidrug resistance in primary human hematopoietic
progenitor cells transduced with optimized retroviral vectors.
Blood 88, 3407-3415.
Boulikas: An overview on gene therapy
138
Einerhand MP, Antoniou M, Zolotukhin S, Muzyczka N, Berns
KI, Grosveld F, Valerio D (1995) Regulated high-level
human β-globin gene expression in erythroid cells following
recombinant adeno-associated virus-mediated gene transfer.
Gene Ther 2, 336-343.
El Ouahabi A, Thiry M, Pector V, Fuks R, Ruysschaert JM,
Vandenbranden M (1997) The role of endosome
destabilizing activity in the gene transfer process mediated
by cationic lipids. FEBS Lett 414, 187-192.
El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B
(1992) Definition of a consensus binding site for p53.
Nature Genet 1, 45-49.
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R,
Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B
(1993) WAF1, a potential mediator of p53 tumor
suppression. Cell 75, 817-825.
Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O, Oren M
(1989) Wild-type p53 can inhibit oncogene-mediated focus
formation. Proc Natl Acad Sci USA 86, 8763-8767.
Elshami AA, Cook JW, Amin KM, Choi H, Park JY, Coonrod L,
Sun J, Molnar-Kimber K, Wilson JM, Kaiser LR, Albelda
SM (1997) The effect of promoter strength in adenoviral
vectors containing herpes simplex virus thymidine kinase on
cancer gene therapy in vitro and in vivo. Cancer Gene Ther
4, 213-221.
Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S,
Robertson M, Ghayur T, Wong WW, Kamen R,
Weichselbaum R, et al (1995) Proteolytic activation of
protein kinase C δ by an ICE-like protease in apoptotic cells.
EMBO J 14, 6148-6156.
Endicott JA and Ling V (1989) The biochemistry of Pglycoprotein-mediated
multidrug resistance. Annu Rev
Biochem 58, 137-171.
Enomaa N, Danos O, Peltonen L, and Jalanko A (1995)
Correction of deficient enzyme activity in a lysosomal
storage disease, aspartylglucosaminuria, by enzyme
replacement and retroviral gene transfer. Hum Gene Ther 6,
723-731.
Evans CH and Robbins PD (1996) Pathways to gene therapy in
rheumatoid arthritis. Curr Opin Rheumatol 8, 230-234.
Evans CH, Robbins PD, Ghivizzani SC, Herndon JH, Kang R,
Bahnson AB, Barranger JA, Elders EM, Gay S, Tomaino
MM, Wasko MC, Watkins SC, Whiteside TL, Glorioso JC,
Lotze MT, Wright TM (1996) Clinical trial to assess the
safety, feasibility, and efficacy of transferring a potentially
anti-arthritic cytokine gene to human joints with rheumatoid
arthritis. Hum Gene Ther 7, 1261-1280.
Fang B, Eisensmith RC, Wang H, Kay MA, Cross RE, Landen
CN, Gordon G, Bellinger DA, Read MS, Hu PC, Brinkhous
KM, and Woo SLC (1995) Gene therapy for hemophilia B:
Host immunosuppression prolongs the therapeutic effect of
adenovirus-mediated factor IX expression. Hum Gene Ther
6, 1039-1044.
Fardel O, Escande F, Drenou B, Le Bescot J, Rault B, and
Fauchet R (1995) Expression of P-glycoprotein in multidrugresistant
human leukemia K562 cells during erythroid
differentiation. Int J Oncol 7, 377-381.